SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 3rd, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • California
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of _________, 2020 (the “Effective Date”) by and among MedAvail, Inc., a Delaware corporation (the “Company”), and the purchasers listed on the signature pages hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in SECTION 9 hereof.
ContractMyos Rens Technology Inc. • September 3rd, 2020 • Pharmaceutical preparations
MANUFACTURING AND SUPPLYAnd Supply Agreement • September 3rd, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Ontario
MedAvail Technologies Inc. (the “CUSTOMER”) a company incorporated and organized under the laws of Ontario with a registered office at: #1 - 6665 Millcreek Dr. Mississauga, Ontario L5N 5M4
ContractSecurity Agreement • September 3rd, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
PRODUCT DISTRIBUTION AGREEMENTProduct Distribution Agreement • September 3rd, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
THIS PRODUCT DISTRIBUTION AGREEMENT (the "Agreement") is made this 25th day of October, 2018, (the "Effective Date") by and between Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation having offices at 255 Technology Park, Lake Mary, Florida 32746 ("Distributor"), and MedAvail Pharmacy Inc., an Arizona corporation having offices at 1430 East Fort Lowell Road, Tucson, Arizona 85719 ("Company"). Distributor and Company are each referred to in this Agreement as a "Party," collectively, the "Parties."
